Most people whose brains exhibit Alzheimer's pathology don’t have the disease; they reach the end of their lives never having exhibited cognitive impairment. A new study examines the genetics of this resilience.

The announcement of the recognition of VMAC as an NIH Center of Excellence comes nearly five years after the creation of an exploratory NIA-funded Alzheimer’s Disease Research Center.

Data from more than 4,000 participants reveals link between brain structure and cognitive decline.  

Santisteban’s research project will investigate whether the renin angiotensin system plays an important role in the progression of pathology in Alzheimer’s disease.

Researchers found that increased sedentary behavior in aging adults was associated with worse cognition and brain shrinkage in areas related to risk for developing Alzheimer’s disease.

A new study will use innovative methods developed at VUMC to look for drugs already approved for other uses that could potentially be repurposed to treat Alzheimer's.

An observational study found that bariatric surgery was associated with 63% reduced risk of Alzheimer's disease and related dementias.